Some COVID long-haulers report having less severe symptoms after getting vaccinated
COVID-19 long-haulers in Utah and beyond have reported improvements to their symptoms after receiving the vaccine.
and last updated 2021-05-10 12:55:02-04
SALT LAKE CITY â When COVID-19 vaccine appointments opened for all Utahns over the age of 16, Andrew Stott said he was hesitant to make an appointment.
As a
COVID long-hauler, Stott was worried what the vaccine could do.
âI was nervous about getting the vaccine and not knowing if I would have a really hard time,â he said.
After a conversation with his doctor, he decided to get the vaccine. He had his second dose a few weeks ago.
The number of reports of injuries and deaths following COVID vaccines continues to rise, according to data released today by the Centers for Disease Control and Prevention (CDC). The data comes directly from reports submitted to the Vaccine Adverse Event Reporting System (VAERS).
VAERS is the primary government-funded system for reporting adverse vaccine reactions in the U.S. Reports submitted to VAERS require further investigation before a causal relationship can be confirmed.
Every Friday, VAERS makes public all vaccine injury reports received as of a specified date, usually about a week prior to the release date. Today’s data show that between Dec. 14, 2020 and April 30, a total of 157,277 total adverse events were reported to VAERS, including 3,837 deaths an increase of 293 over the previous week and 16,014 serious injuries, up 2,467 since last week.
Salt Lake City doctors say a man under 50 got the Johnson&Johnson COVID-19 vaccine in April and started experiencing leg pain about 10 days later. The CDC is investigating the case. Meanwhile, Utah’s number of COVID-19 cases increased by 480 on Wednesday, with two more deaths and 18,687 new vaccinations reported.
by Vasilios Nassiopoulos, Vice President of Platform Strategy and Innovation, Hayes
Vasilios Nassiopoulos, Vice President of Platform Strategy and Innovation, Hayes
Healthcare organizations have witnessed an explosion of new opportunities to extract value from the industry’s treasure trove of data in recent years, with success stories related to using advanced technology such as artificial intelligence (AI) and machine learning found in every sector.
Revenue integrity is no exception.
Error-prone manual processes that were formerly characterized by painstaking line-by-line analyses of claims are giving way to automation and analytics that can support more efficient and effective auditing practices essentially moving strategy from reactive to proactive for a healthier bottom line.
Joint 3i/U2M2 project grants open pathways for infectious disease research University of Utah Health | May 6, 2021
Share this:
The University of Utah Health Immunology, Inflammation and Infectious Disease Initiative (3i), in conjunction with the University of Utah Molecular Medicine program (U2M2), has awarded program planning grants to four collaborative research projects. The funded projects will explore alternative treatments and diagnoses for many human disorders, including viral infections and sepsis.
“The Program Planning Grants are the natural next step from our previous grants aimed at building new collaborative teams,” says Ryan O’Connell, Ph.D., director of the 3i Initiative and an associate professor in Pathology at U of U Health. These previously funded teams and other groups fortified by new faculty recruits have matured to compete for large multi-PI grants. This program gives these teams the added resources needed to earn a fundable score by